[Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan].
Yamamoto, Tomoya; Murai, Tasuku; Ueda, Mikiko; Katsuura, Masato; Oishi, Masako; Miwa, Yoshihiro; Okamoto, Yoshiaki; Uejima, Etsuko; Taguchi, Tetsuya; Noguchi, Shinzaburo; Kurokawa, Nobuo.
Gan To Kagaku Ryoho
; 36(1): 89-92, 2009 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-19151569
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.
BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer Patients.
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis.
Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy.
[Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy].
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
[A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].